Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FH5EQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $65,633
Award facts
- Contract value 100% obligated
- $65,633.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $65,633.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 mL vials. This delivery order, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, represents a specific fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $500 million through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for pharmaceutical products supporting the medical supply needs of military healthcare facilities worldwide. No set-aside designation was applied to this award.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through its core business of distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. The company's extensive contract portfolio demonstrates consistent performance delivering high-value pharmaceutical products, including oncology treatments and specialty medications, directly to military health facilities. As the prime contractor on this delivery order, DMS Pharmaceutical Group will serve as the sole source for Keytruda supplies under this award, leveraging its established position within the DLA's pharmaceutical procurement framework.
Quick answers
Who was awarded contract SPE2DB25FH5EQ?
SPE2DB25FH5EQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FH5EQ worth?
The government has obligated $65,633 on SPE2DB25FH5EQ.
Is contract SPE2DB25FH5EQ an order under another contract?
Yes. SPE2DB25FH5EQ is a delivery order under SPE2DB22D9207, an indefinite delivery contract.
Was contract SPE2DB25FH5EQ competed?
The extent of competition for SPE2DB25FH5EQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award